(via Anti-Nuclear Antibody (ANA) Testing Market | Trends & Forecasts 2025-2032)
The Antinuclear Antibody (ANA) Testing Market is set to nearly double, reaching US$4.9 billion by 2032 at a CAGR of 12.5%. Rising autoimmune diseases, advanced multiplex assays, and AI-driven diagnostics are fueling demand worldwide.







